Fundraising Fox

Medical Devices Late Stage Investors & VC Firms

489 firms in this list, with a median first check of $1.1M. 105 of them lead rounds. Generated from verified public data and updated continuously.

Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
22 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
Accelmed Partners
MiamiPre-Seed–Late Stage
10 people
Sixty Degree Capital
North YorkPre-Seed–Late Stage
16 people
Mountain Group Capital
NashvillePre-Seed–Late Stage
13 people
Norrsken22
JohannesburgSeed–Late Stage
16 people
Vensana Capital
MinneapolisSeries A–Late Stage
13 people
LYFE Capital
Menlo ParkSeed–Late Stage
16 people
Mission Bay Capital
San FranciscoPre-Seed–Late Stage
13 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Redesign Health
New YorkSeed–Late Stage
18 people
Wasatch Equity Partners
LoganSeed–Late Stage$1M – $100M
11 people
Robin Hood Ventures
PhiladelphiaSeed–Late Stage$250K – $1M
2 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Puhua Capital
HangzhouPre-Seed–Late Stage$1.4M – $112M
Brightstone Venture Capital
MinneapolisSeed–Late Stage$250K – $10M
11 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
13 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
17 people
Mérieux Equity Partners
ParisSeed–Late Stage$3.2M – $86M
14 people
Kernel Capital
CorkSeed–Late Stage$1.1M – $5.4M
10 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.